Back
Cytek Biosciences 10K Form
Sell
16
CTKB
Cytek Biosciences
Last Price:
6.10
Seasonality Move:
42.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTKB News And Ratings
See the #1 stock for the next 7 days that we like better than CTKB
CTKB Financial Statistics
Sales & Book Value
| Annual Sales: | $193.02M |
|---|---|
| Cash Flow: | $3.34M |
| Price / Cash Flow: | 569.81 |
| Annual Sales: | $2.99 |
| Price / Book: | 2.04 |
Profitability
| EPS (TTM): | -0.09000 |
|---|---|
| Net Income (TTM): | $-11.51M |
| Gross Margin: | $109.43M |
| Return on Equity: | -2.81% |
| Return on Assets: | -2.25% |
Cytek Biosciences Earnings Forecast
Key Cytek Biosciences Financial Ratios
- The Gross Profit Margin over the past 5 years for CTKB is 56.69%.
- The Selling, General & Administrative Expenses for CTKB have been equal to 48.24% of Gross Profit Margin.
- The Research & Development expenses have been 22.87% of Revenue.
- The Interest Expense is -17.05% of Operating Income.
- The Net Earning history of CTKB is -6.29% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Cytek Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CTKB |
| Website: | cytekbio.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 6.99 |
| Quick Ratio: | 5.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 32.97 |
CTKB Technical Analysis vs Fundamental Analysis
Sell
16
Cytek Biosciences (CTKB)
is a Sell
Is Cytek Biosciences a Buy or a Sell?
-
Cytek Biosciences stock is rated a Sell
The current Cytek Biosciences [CTKB] share price is $6.10. The Score for CTKB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.